By Michael Knight, KFWB news anchor
We know aspirin relieves pain and prevents heart attacks. Now we learn through a new study it may also help reduce a woman’s risk for melanoma, the most dangerous type of skin cancer.
Researchers found that post-menopausal women who used aspirin two or more times a week had a 21 percent lower risk of developing melanoma than women who did not take the pain reliever. These results held true for aspirin use only.
“Aspirin works on a slightly different inflammatory pathways and some of these pathways may be specific to melanoma,” according to the study released today in the journal Cancer.
Seventy-five percent of aspirin users reported taking a regular strength aspirin, which is usually 325 milligrams, at least twice a week, while 25 percent took low-dose baby aspirin. The exact dosage and frequency of their overall aspirin use is not known.
The findings showed that the longer the women took aspirin, the greater the protection it offered against this type of skin cancer. Women who had used aspirin at least twice a week for five or more years reduced their odds of developing melanoma by 30 percent compared to non-aspirin users.